Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Quality assurance program for peripheral blood mononuclear cell cryopreservation.

Weinberg A, Louzao R, Mussi-Pinhata MM, Cruz ML, Pinto JA, Huff MF, de Castro AC, Sucupira MC, Denny TN.

Clin Vaccine Immunol. 2007 Sep;14(9):1242-4. Epub 2007 Jul 25.

2.

Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal.

Ducar C, Smith D, Pinzon C, Stirewalt M, Cooper C, McElrath MJ, Hural J; NIAID HIV Vaccine Trials Network.

J Immunol Methods. 2014 Jul;409:9-20. doi: 10.1016/j.jim.2014.03.024. Epub 2014 Apr 4.

3.

Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples.

Dyer WB, Pett SL, Sullivan JS, Emery S, Cooper DA, Kelleher AD, Lloyd A, Lewin SR.

Clin Vaccine Immunol. 2007 Jan;14(1):52-9. Epub 2006 Oct 18.

4.

The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.

Sarzotti-Kelsoe M, Needham LK, Rountree W, Bainbridge J, Gray CM, Fiscus SA, Ferrari G, Stevens WS, Stager SL, Binz W, Louzao R, Long KO, Mokgotho P, Moodley N, Mackay M, Kerkau M, McMillion T, Kirchherr J, Soderberg KA, Haynes BF, Denny TN.

J Immunol Methods. 2014 Jul;409:21-30. doi: 10.1016/j.jim.2014.05.013. Epub 2014 Jun 5.

6.

The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy.

Heo YJ, Son CH, Chung JS, Park YS, Son JH.

Cryobiology. 2009 Apr;58(2):203-9. doi: 10.1016/j.cryobiol.2008.12.006. Epub 2008 Dec 25.

PMID:
19152796
7.

T cell responses in fresh and cryopreserved peripheral blood mononuclear cells: kinetics of cell viability, cellular subsets, proliferation, and cytokine production.

Jeurink PV, Vissers YM, Rappard B, Savelkoul HF.

Cryobiology. 2008 Oct;57(2):91-103. doi: 10.1016/j.cryobiol.2008.06.002. Epub 2008 Jun 13.

PMID:
18593572
8.

Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting.

Olemukan RE, Eller LA, Ouma BJ, Etonu B, Erima S, Naluyima P, Kyabaggu D, Cox JH, Sandberg JK, Wabwire-Mangen F, Michael NL, Robb ML, de Souza MS, Eller MA.

Clin Vaccine Immunol. 2010 Jun;17(6):910-8. doi: 10.1128/CVI.00492-09. Epub 2010 Mar 3.

9.

Apoptosis: a method for evaluating the cryopreservation of whole blood and peripheral blood mononuclear cells.

Fowke KR, Behnke J, Hanson C, Shea K, Cosentino LM.

J Immunol Methods. 2000 Oct 20;244(1-2):139-44.

PMID:
11033026
10.

Value of a quality assessment program in optimizing cryopreservation of peripheral blood mononuclear cells in a multicenter study.

Aziz N, Margolick JB, Detels R, Rinaldo CR, Phair J, Jamieson BD, Butch AW.

Clin Vaccine Immunol. 2013 Apr;20(4):590-5. doi: 10.1128/CVI.00693-12. Epub 2013 Feb 13.

11.

Cryopreservation of peripheral blood mononuclear cells does not significantly affect the levels of spontaneous apoptosis after 24-h culture.

Riccio EK, Neves I, Banic DM, Corte-Real S, Alecrim Md, Morgado M, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F.

Cryobiology. 2002 Oct;45(2):127-34.

PMID:
12482378
12.

Cryopreserved peripheral blood mononuclear cells are suitable for the assessment of immunological markers in type 1 diabetic children.

Axelsson S, Faresjö M, Hedman M, Ludvigsson J, Casas R.

Cryobiology. 2008 Dec;57(3):201-8. doi: 10.1016/j.cryobiol.2008.08.001. Epub 2008 Aug 12.

PMID:
18761006
13.

Viability and functional activity of cryopreserved mononuclear cells.

Weinberg A, Zhang L, Brown D, Erice A, Polsky B, Hirsch MS, Owens S, Lamb K.

Clin Diagn Lab Immunol. 2000 Jul;7(4):714-6.

14.

Use of trypan blue staining to assess the quality of ovarian cryopreservation.

Fauque P, Ben Amor A, Joanne C, Agnani G, Bresson JL, Roux C.

Fertil Steril. 2007 May;87(5):1200-7. Epub 2007 Feb 20.

PMID:
17307173
15.

Towards a xeno-free and fully chemically defined cryopreservation medium for maintaining viability, recovery, and antigen-specific functionality of PBMC during long-term storage.

Schulz JC, Germann A, Kemp-Kamke B, Mazzotta A, von Briesen H, Zimmermann H.

J Immunol Methods. 2012 Aug 31;382(1-2):24-31. doi: 10.1016/j.jim.2012.05.001. Epub 2012 May 8.

16.

Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.

Reich-Slotky R, Colovai AI, Semidei-Pomales M, Patel N, Cairo M, Jhang J, Schwartz J.

Vox Sang. 2008 May;94(4):351-7. doi: 10.1111/j.1423-0410.2007.001028.x. Epub 2008 Jan 2.

PMID:
18179677
17.

Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study.

Kleeberger CA, Lyles RH, Margolick JB, Rinaldo CR, Phair JP, Giorgi JV.

Clin Diagn Lab Immunol. 1999 Jan;6(1):14-9.

18.

Issues concerning the large scale cryopreservation of peripheral blood mononuclear cells (PBMC) for immunotherapy trials.

Best A, Hidalgo G, Mitchell K, Yannelli JR.

Cryobiology. 2007 Jun;54(3):294-7. Epub 2007 Feb 28.

PMID:
17433284
19.

Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays.

Weinberg A, Song LY, Wilkening CL, Fenton T, Hural J, Louzao R, Ferrari G, Etter PE, Berrong M, Canniff JD, Carter D, Defawe OD, Garcia A, Garrelts TL, Gelman R, Lambrecht LK, Pahwa S, Pilakka-Kanthikeel S, Shugarts DL, Tustin NB.

J Immunol Methods. 2010 Dec 15;363(1):42-50. doi: 10.1016/j.jim.2010.09.032. Epub 2010 Oct 1.

20.

Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials.

Bull M, Lee D, Stucky J, Chiu YL, Rubin A, Horton H, McElrath MJ.

J Immunol Methods. 2007 Apr 30;322(1-2):57-69. Epub 2007 Feb 28.

Items per page

Supplemental Content

Write to the Help Desk